252 related articles for article (PubMed ID: 21784901)
1. Allelic variants of complement genes associated with dense deposit disease.
Abrera-Abeleda MA; Nishimura C; Frees K; Jones M; Maga T; Katz LM; Zhang Y; Smith RJ
J Am Soc Nephrol; 2011 Aug; 22(8):1551-9. PubMed ID: 21784901
[TBL] [Abstract][Full Text] [Related]
2. Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease).
Abrera-Abeleda MA; Nishimura C; Smith JL; Sethi S; McRae JL; Murphy BF; Silvestri G; Skerka C; Józsi M; Zipfel PF; Hageman GS; Smith RJ
J Med Genet; 2006 Jul; 43(7):582-9. PubMed ID: 16299065
[TBL] [Abstract][Full Text] [Related]
3. Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies.
Servais A; Noël LH; Roumenina LT; Le Quintrec M; Ngo S; Dragon-Durey MA; Macher MA; Zuber J; Karras A; Provot F; Moulin B; Grünfeld JP; Niaudet P; Lesavre P; Frémeaux-Bacchi V
Kidney Int; 2012 Aug; 82(4):454-64. PubMed ID: 22456601
[TBL] [Abstract][Full Text] [Related]
4. FHR-5 Serum Levels and
Garam N; Cserhalmi M; Prohászka Z; Szilágyi Á; Veszeli N; Szabó E; Uzonyi B; Iliás A; Aigner C; Schmidt A; Gaggl M; Sunder-Plassmann G; Bajcsi D; Brunner J; Dumfarth A; Cejka D; Flaschberger S; Flögelova H; Haris Á; Hartmann Á; Heilos A; Mueller T; Rusai K; Arbeiter K; Hofer J; Jakab D; Sinkó M; Szigeti E; Bereczki C; Janko V; Kelen K; Reusz GS; Szabó AJ; Klenk N; Kóbor K; Kojc N; Knechtelsdorfer M; Laganovic M; Lungu AC; Meglic A; Rus R; Kersnik Levart T; Macioniene E; Miglinas M; Pawłowska A; Stompór T; Podracka L; Rudnicki M; Mayer G; Rysava R; Reiterova J; Saraga M; Seeman T; Zieg J; Sládková E; Stajic N; Szabó T; Capitanescu A; Stancu S; Tisljar M; Galesic K; Tislér A; Vainumäe I; Windpessl M; Zaoral T; Zlatanova G; Józsi M; Csuka D
Front Immunol; 2021; 12():720183. PubMed ID: 34566977
[TBL] [Abstract][Full Text] [Related]
5. Causes of alternative pathway dysregulation in dense deposit disease.
Zhang Y; Meyer NC; Wang K; Nishimura C; Frees K; Jones M; Katz LM; Sethi S; Smith RJ
Clin J Am Soc Nephrol; 2012 Feb; 7(2):265-74. PubMed ID: 22223606
[TBL] [Abstract][Full Text] [Related]
6. Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation.
Martínez-Barricarte R; Heurich M; Valdes-Cañedo F; Vazquez-Martul E; Torreira E; Montes T; Tortajada A; Pinto S; Lopez-Trascasa M; Morgan BP; Llorca O; Harris CL; Rodríguez de Córdoba S
J Clin Invest; 2010 Oct; 120(10):3702-12. PubMed ID: 20852386
[TBL] [Abstract][Full Text] [Related]
7. Streptococcal infection as possible trigger for dense deposit disease (C3 glomerulopathy).
Prasto J; Kaplan BS; Russo P; Chan E; Smith RJ; Meyers KE
Eur J Pediatr; 2014 Jun; 173(6):767-72. PubMed ID: 24384791
[TBL] [Abstract][Full Text] [Related]
8. C3 glomerulopathy.
Servais A; Noël LH; Frémeaux-Bacchi V; Lesavre P
Contrib Nephrol; 2013; 181():185-93. PubMed ID: 23689580
[TBL] [Abstract][Full Text] [Related]
9. Complement factor H-related hybrid protein deregulates complement in dense deposit disease.
Chen Q; Wiesener M; Eberhardt HU; Hartmann A; Uzonyi B; Kirschfink M; Amann K; Buettner M; Goodship T; Hugo C; Skerka C; Zipfel PF
J Clin Invest; 2014 Jan; 124(1):145-55. PubMed ID: 24334459
[TBL] [Abstract][Full Text] [Related]
10. Eculizumab for dense deposit disease and C3 glomerulonephritis.
Bomback AS; Smith RJ; Barile GR; Zhang Y; Heher EC; Herlitz L; Stokes MB; Markowitz GS; D'Agati VD; Canetta PA; Radhakrishnan J; Appel GB
Clin J Am Soc Nephrol; 2012 May; 7(5):748-56. PubMed ID: 22403278
[TBL] [Abstract][Full Text] [Related]
11. Gene polymorphism of complement factor H in a Turkish patient with membranoproliferative glomerulonephritis type II.
Sozeri B; Mir S; Berdeli A; Dincel N; Sarsik B
Iran J Kidney Dis; 2012 Mar; 6(2):149-53. PubMed ID: 22388616
[TBL] [Abstract][Full Text] [Related]
12. A novel CFHR5 mutation associated with C3 glomerulonephritis in a Turkish girl.
Besbas N; Gulhan B; Gucer S; Korkmaz E; Ozaltin F
J Nephrol; 2014 Aug; 27(4):457-60. PubMed ID: 24536001
[TBL] [Abstract][Full Text] [Related]
13. C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up.
Sethi S; Fervenza FC; Zhang Y; Zand L; Vrana JA; Nasr SH; Theis JD; Dogan A; Smith RJ
Kidney Int; 2012 Aug; 82(4):465-73. PubMed ID: 22673887
[TBL] [Abstract][Full Text] [Related]
14. Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement.
Sethi S; Fervenza FC; Zhang Y; Nasr SH; Leung N; Vrana J; Cramer C; Nester CM; Smith RJ
Clin J Am Soc Nephrol; 2011 May; 6(5):1009-17. PubMed ID: 21415311
[TBL] [Abstract][Full Text] [Related]
15. C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and C3 glomerulonephritis.
Xiao X; Pickering MC; Smith RJ
Semin Thromb Hemost; 2014 Jun; 40(4):465-71. PubMed ID: 24799308
[TBL] [Abstract][Full Text] [Related]
16. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
Licht C; Fremeaux-Bacchi V
Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of C3 glomerulopathy in children: a single-center experience.
Drake KA; Ellington N; Gattineni J; Torrealba JR; Hendricks AR
Pediatr Nephrol; 2020 Jan; 35(1):153-162. PubMed ID: 31667615
[TBL] [Abstract][Full Text] [Related]
18. A CHILD WITH DENSE DEPOSIT DISEASE AND DECREASED CLASSIC COMPLEMENT PATHWAY ACTIVITY.
Trutin I; Oletić L; Galešić Ljubanović D; Turudić D; Milošević D
Acta Clin Croat; 2021 Mar; 60(1):141-145. PubMed ID: 34588735
[TBL] [Abstract][Full Text] [Related]
19. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration.
Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB
Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792
[TBL] [Abstract][Full Text] [Related]
20. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P; Daina E; Curreri M; Piras R; Valoti E; Mele C; Bresin E; Gamba S; Alberti M; Breno M; Perna A; Bettoni S; Sabadini E; Murer L; Vivarelli M; Noris M; Remuzzi G; ;
J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
